Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationCrosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironmentCCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.CCL21 Cancer Immunotherapy.Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer.Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinomaThe evolving role of dendritic cells in cancer therapy.Developing an effective breast cancer vaccine.Chemokines: can effector cells be redirected to the site of the tumor?New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived CancersPGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.
P2860
Q26796395-58F2B564-A0E7-4BFF-B567-C1D39E928270Q28081431-713015ED-1DB5-4B3B-8261-FB7769222481Q33726546-C859B896-BE18-40AA-85CE-F685E697D3BEQ33820300-12EDDB69-26AC-4CE9-B38F-DB787449E1FAQ35713347-98FC40B1-7F39-4429-B59B-B90E4D7D04A3Q36828493-2B2EC41C-E9BB-4D1D-BB04-5F5EF995C6ABQ37371177-F61DEADB-690B-490E-B334-B06225D1D7B8Q37557653-6A39DD35-B1C1-4969-9B08-264550C1FAB2Q37687418-A61D6149-4BC3-4F28-A28E-70CB18D031AEQ37776145-EE7FB903-87E7-471C-9EF3-819503FACC6CQ37778693-0E8804C9-53D7-40C0-9D47-C9D4C7B36FAFQ37820489-66A721F3-B88A-42DE-AA27-B0FEF83D2F97Q40517920-2C18F412-64A6-4B6D-96B3-509EC5A90EFFQ41457800-B0696CA7-9480-467B-9597-1E2D1463A5C8Q46502766-7FE7DA70-EDF5-4B76-BB75-A93FF41C586AQ52665504-29DF4412-1F46-4AF6-8890-CCC762093E65
P2860
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@ast
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@en
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@nl
type
label
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@ast
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@en
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@nl
prefLabel
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@ast
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@en
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@nl
P2093
P2860
P356
P1433
P1476
Overexpression of CCL-21/secon ...... s and antigen presenting cells
@en
P2093
Brian Escuadro
Felicita Baratelli
Karen Riedl
Robert Figlin
Robert Strieter
Seok Chul Yang
Sherven Sharma
Steven Dubinett
P2860
P2888
P356
10.1186/1476-4598-2-35
P407
P50
P577
2003-11-02T00:00:00Z
P5875
P6179
1036518689